Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
...
Next
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Jun 24, 2022 6:54am
RE:Interview with Dr. Bieber
Sounds like he is doing what Howard should have done years ago. Definitely sounds like more than an "Advisor" the way he talks in the interview. Everything he says seems to be right
...more
(26)
•••
24minus7
X
View Profile
View Bullboard History
Post by
24minus7
on Jun 24, 2022 2:54am
Interview with Dr. Bieber
https://twitter.com/PRCexposure/status/1540214958536814592?s=20&t=nf6JFA6aZFBHVrxYzFUuiwhttps://twitter.com/PRCexposure/status/1540214958536814592?s=20&t=nf6JFA6aZFBHVrxYzFUuiwhttps://twitter
...more
Discover Options Trading Strategies to Minimize your Tax Burden
posted Dec 01, 2024 9:00am by
Bank of Montreal
-
|
Options trading doesn’t come without tax implications, but there are ways investors can still optimize their after-tax returns with just a little bit of understanding. Approaches for investors to keep in mind are holding periods, wash-sales rule, tax advantaged accounts, and qualified cover calls. BMO’s enhanced InvestorLine platform. Industry-leading tools and capabilities specifically designed to empower options traders. ...read more
(80)
•••
bealert
X
View Profile
View Bullboard History
Post by
bealert
on Jun 23, 2022 3:34pm
To Navajojoe
Why don't you tweet that lady in your link and tell her about Sirona and their product. Maybe that will give us huge mileage. I personally don't do any social media or I would figure
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Post by
biorun
on Jun 23, 2022 2:37pm
Sirona now a “Strong Buy”
https://www.barchart.com/stocks/quotes/SBM.VN/overview
(1978)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 23, 2022 2:14pm
RE:Abbvie/Allergan and Sirona
Slide 9. Co. should footnote where it got the $8 billion no. for the dark spot corrector mkt like it did for the cellulite market. If no link assume BS.
(101)
•••
biorun
X
View Profile
View Bullboard History
Post by
biorun
on Jun 23, 2022 11:34am
Abbvie/Allergan and Sirona
yes, the data on hydroquinone is a starting point, but its been outlawed in many important markets and regions and discontinued by the majors for some time now, and they had to resort to temporary
...more
(1978)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 23, 2022 10:03am
RE:RE:RE:RE:Market size?
note: use of hydroquinone for skin creams is a subset of this..... Due to the COVID-19 pandemic, the global Hydroquinone market size is estimated to be worth USD 445 million in 2022 and is
...more
(11)
•••
Transperance
X
View Profile
View Bullboard History
Comment by
Transperance
on Jun 23, 2022 9:34am
RE:RE:RE:Market size?
Agree with you. When the customers understand that there are non-toxic products available, the market will likely grow at a faster rate.
(101)
•••
biorun
X
View Profile
View Bullboard History
Post by
biorun
on Jun 23, 2022 7:38am
Transperence - nice post
You got it. thanks for that.
(11)
•••
Transperance
X
View Profile
View Bullboard History
Post by
Transperance
on Jun 23, 2022 5:47am
What mood are you guys in?
I really don’t understand the mood of some of you here. We have been waiting for this 1067 transaction since Neil and now finally, when the deal is nailed, we should be happy.
...more
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Post by
SleepyHoward
on Jun 23, 2022 4:56am
great
https://www.youtube.com/watch?v=cV8NnWMKQcU
(1978)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 23, 2022 2:07am
RE:Market size?
Market Insight Reports projects the global hyperpigmentation treatment market will accelerate at a compound annual growth rate of 8.3% to reach $677.4 million by 2027, up from $387.7 million
...more
(12)
•••
LakeOromocto
X
View Profile
View Bullboard History
Post by
LakeOromocto
on Jun 22, 2022 10:42pm
News from a different source
https://zexprwire.com/abbvie-signs-licensing-deal-with-sirona-biochem-for-effective-new-hydroquinone-alternative/
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jun 22, 2022 7:54pm
RE:RE:RE:Shorts increased by 507,470
Good thing we don't have to worry about this. No hedge fund will go near it, not enough market cap or liquidity.
Prev
...
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >